Similar to the reported decline in expression of this protein in end-stage AD in humans, 3xTg AD mice with more advanced AD pathology (14-month-old) showed significantly reduced levels of ASAH2 expression in the liver (Figure 3C). Here, ASAH2 is linked to Alzheimer disease.